Bionano Q4 2025 revenue $8.0M (-3% YoY); FY revenue $28.5M (-7%)

Bionano Genomics, Inc.

Q4 2025 revenue $8.0M vs $8.2M Q4 2024; consumables/software revenue down 1%.
Full-year 2025 revenue $28.5M vs $30.8M FY2024; consumables/software up 7%.
Q4 gross margin 43% (42% prior); non-GAAP gross margin also 43%.
Operating expenses reduced 22% to $11.9M in Q4; installed base 387 systems (+4%).
Company provided 2026 revenue outlook (specific figures not available in excerpt).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.